Asthma is narrowing of the airway of lungs caused by inflammation in the air passage resulting from both genetic and environmental influences.Allergic asthma is the most common form of asthma.Allergic asthma is triggered by inhaled allergens, such as dust mite allergen, pet dander, pollen, mold, resulting in asthma symptoms.The symptoms of allergic asthma are coughing, wheezing, shortness of breath or rapid breathing and chest tightness. Triggers cause inflammation (swelling and redness) in the airway.
Allergic Asthma - Pipeline Review, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Allergic Asthma, with latest updates. Some of the players involved in the therapeutic development for Allergic asthma are Novartis, Pfizer, F. Hoffmann-La Roche, Panacea Biotec, AstraZeneca, Genentech, Infinity Pharmaceuticals, Portola Pharmaceuticals,ASKA Pharmaceuticaland Trident Pharmaceuticals.
Scope
- The report provides a snapshot of the global Allergic Asthma Drugs Market.
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the development of Allergic Asthma Drugs and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- Coverage of the Allergic Asthma Drugs pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products
